Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. News
  3. swelling edema
Show results for
Products
Applications
Companies
News
Articles
Refine by
Date

Swelling Edema Articles & Analysis

1 news found
Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion

Bayer initiates phase III study to investigate aflibercept 8 mg in retinal vein occlusion

The phase III QUASAR clinical trial in macular edema secondary to RVO follows the application for regulatory authorization of aflibercept 8 mg in the EU, Japan, and other markets for the treatment of nAMD and DME. ...

ByBayer AG

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you